Skip to content

Acute Immunological Effects of Exercise in Cancer Patients

ACTIVE- Acute Effects of a Single Physical Exercise Intervention on Immune Cells and Inflammation in Cancer Patients and a Healthy Comparison Group

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05656651
Acronym
ACTIVE
Enrollment
60
Registered
2022-12-19
Start date
2022-12-19
Completion date
2025-07-31
Last updated
2024-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The aim of the study is to evaluate and compare immune response to a single exercise intervention in cancer patients and healthy age-maged individuals.

Interventions

Endurance training adapted to age, resting heart rate

Sponsors

Universität Duisburg-Essen
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adolescents and young adults \>14 years of age * undergoing acute cancer treatment (chemotherapy) * signed informed consent

Exclusion criteria

* Inability to follow and implement test instructions * medical contraindication to HIIT on cycle ergometer * chemotherapeutic treatment 48 h prior * Hb \<8g/dl; platelets \< 20,000/ul.

Design outcomes

Primary

MeasureTime frameDescription
Number of Natural Killer CellsChange from pre Intervention to immediately after intervention and 1 hour post interventionNK cells, subgroups and innate lymphoid cells

Secondary

MeasureTime frameDescription
Subjective Quality of LifeOnce after interventionQuality of Life (EORTC QLQ-C30, questionnaire score from 0 - 100, higher score = better quality of life)
FatigueOnce after interventionFatigue (EORTC QLQ FA12 Fatigue questionnaire range 0 - 100, higher score = worse outcome)
Nutritional statusOnce after interventionMini Nutritional Assessment (MNA range 0 - 14 points), lower score = worse

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026